# Nanovex Biotechnologies, S.L.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanovex-biotechnologies-s-l

- Industry: Biotechnology
- Headquarters: Spain
- Website: www.nanovexbiotech.com/
- Latest round: Seed
- Investors on record: 1

## About

Based in Llanera, Spain, and founded in 2014, Nanovex Biotechnologies, S.L. operates as a biotechnology company that develops and manufactures nano-delivery systems. In 2015, the firm raised EUR 100,000 in seed funding led by investor Sociedad Regional de Promoción del Principado de Asturias. The firm as of November 2023, is led by its CEO, Daniel Pando and CSO, Rebeca Alonso. 

The company offers nanopharmaceutical solutions such as designing, developing, and manufacturing nano-systems that address issues related to drug efficacy, toxicity, and bioavailability. Nanovex Biotechnologies' nanocarriers are engineered to load, protect, and deliver therapeutic compounds precisely, ensuring that therapeutic agents reach their intended targets more effectively where needed. These nanosystems enhance drug solubility, protect against external agents, and allow controlled release. The company’s solutions have applications in pharmaceutical and dermocosmetics. Nanovex’s nanocapsules improve oral bioavailability, target specific tissues, and reduce toxicity problems.

## Funding rounds

- Seed, date not disclosed — Sociedad Regional de Promoción del Principado de Asturias

## Investors

- Sociedad Regional de Promoción del Principado de Asturias (https://capitalatlas.ai/funds/sociedad-regional-de-promocion-del-principado-de-asturias) — Seed